Financhill
Back

Incyte 10K Form

Buy
55

INCY
Incyte

Last Price:
$71.11
Seasonality Move:
0.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive INCY News And Ratings

See the #1 stock for the next 7 days that we like better than INCY

INCY Financial Statistics

Sales & Book Value

Annual Sales: $4.2B
Cash Flow: $363.8M
Price / Cash Flow: 63.82
Annual Sales: $17.82
Price / Book: 3.97

Profitability

EPS (TTM): 0.27000
Net Income (TTM): $32.6M
Gross Margin: $3.9B
Return on Equity: 0.81%
Return on Assets: 0.56%

Incyte Earnings Forecast

Key Incyte Financial Ratios

  • The Gross Profit Margin over the past 32 years for INCY is 92.64%.
  • The Selling, General & Administrative Expenses for INCY have been equal to 28.81% of Gross Profit Margin.
  • The Research & Development expenses have been 61.46% of Revenue.
  • The Interest Expense is 6.99% of Operating Income.
  • The Net Earning history of INCY is 0.77% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 18 years.

Incyte Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INCY
CUSIP: 45337C
Website: incyte.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.97
Quick Ratio: 1.83

Price-to-Earnings

Trailing P/E Ratio: 471.93
Forward P/E Ratio: 10.56

INCY Technical Analysis vs Fundamental Analysis

Buy
55
Incyte (INCY) is a Buy

Is Incyte a Buy or a Sell?

  • Incyte stock is rated a Buy
    The current Incyte [INCY] share price is $70.79. The Score for INCY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.